Persistence of Helicobacter pylori in the oral cavity after systemic eradication therapy.

J Clin Periodontol

Department of Stomatology, Division of Periodontology, School of Dentistry, University of São Paulo, São Paulo, Brazil.

Published: May 2006

Aim: The present study aimed to evaluate if the oral cavity of chronic periodontitis patients can harbor Helicobacter pylori after systemic eradication therapy.

Materials And Methods: Samples of 30 patients (15 with gingivitis and 15 with chronic periodontitis) positive for H. pylori in the stomach were evaluated. Samples were collected 3 months after triple systemic antibiotic therapy from saliva, microbiota from the dorsum of the tongue, supra- and sub-gingival plaque as well as gastric biopsies. DNA of each sample was extracted by the boiling method and used as a template in polymerase chain reaction with the primers JW22/23.

Results: Eighteen patients (60%) harboured H. pylori in their mouths. Five patients (16.6%) were positive in saliva, two (6.6%) on the dorsum of the tongue, nine (30%) in supra-gingival plaque, 14 (46.6%) in sub-gingival plaque and three (10%) in the stomach. There was no statistically significant difference between study groups.

Conclusion: Eradication of H. pylori after therapy was more effective for the stomach than for the mouth (p<0.001). Mouths of patients with gingivitis or with chronic periodontitis, who are positive for H. pylori in their stomachs, may be considered as reservoirs of these bacteria.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-051X.2006.00915.xDOI Listing

Publication Analysis

Top Keywords

helicobacter pylori
8
oral cavity
8
systemic eradication
8
chronic periodontitis
8
dorsum tongue
8
sub-gingival plaque
8
pylori
5
persistence helicobacter
4
pylori oral
4
cavity systemic
4

Similar Publications

Pivotal role of virulence genes in pathogenicity and vaccine development.

Front Med (Lausanne)

January 2025

Department of Veterinary Preventive Medicine, College of Veterinary Medicine, Qassim University, Buraydah, Saudi Arabia.

One of the most prevalent human infections is (), which affects more than half of the global population. Although infections are widespread, only a minority of individuals develop severe gastroduodenal disorders. The global resistance of to antibiotics has reached concerning levels, significantly impacting the effectiveness of treatment.

View Article and Find Full Text PDF

Gastric cancer remains a significant global health challenge, with Helicobacter pylori (H. pylori) recognized as a major etiological agent, affecting an estimated 50% of the world's population. There has been a rapidly expanding knowledge of the molecular and pathogenetic mechanisms of H.

View Article and Find Full Text PDF

Co-culture of Helicobacter pylori with oral microorganisms in human saliva.

Clin Oral Investig

January 2025

Department of Operative Dentistry and Periodontology, Center for Dental Medicine, Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, University of Freiburg, Freiburg, Germany.

Objective: Helicobacter pylori is known for colonizing the gastric mucosa and instigating severe upper gastrointestinal diseases such as gastritis, gastroduodenal ulcers, and gastric cancer. To date, there is no data available on the oral cavity as transmission site, whether H. pylori can survive in the oral cavity or in human saliva.

View Article and Find Full Text PDF

The Incidence and Implication of Helicobacter pylori Infection in the Setting of Reinke's Edema.

J Voice

January 2025

Department of Otolaryngology - Head and Neck Surgery, School of Medicine,  Louisiana State University, Shreveport, LA 71103.

Objective(s): To assess the prevalence of Helicobacter pylori in Reinke's edema patients. To evaluate and compare the disease severity of patients who are H. pylori positive with those who are H.

View Article and Find Full Text PDF

Antibodies directed against bacterial antigens in sera of Polish patients with primary biliary cholangitis.

Front Cell Infect Microbiol

January 2025

Clinic of Polish Gastroenterology Foundation, Warsaw, Poland.

Background: Primary biliary cholangitis (PBC) is a cholestatic, autoimmune liver disease with the presence of characteristic autoantibodies. The aim of the work was to determine the level of antibodies directed against bacterial antigens: (anti-anti), (anti-), (anti- ) and () in sera of PBC patients. We also performed studies on the impact of the bacterial peptides on the specific antigen-antibody binding.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!